Search

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal residual disease (MRD) responses compared to VRd alone in patients with newly diagnosed, transplant-ineligible multiple myeloma.

… Monday, February 17, 2025 UPDATE January 27, 2026: The U.S. Food and Drug Administration (FDA)  approved  the quadruplet therapy daratamumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of adult patients with newly

Memorial Sloan Kettering Cancer Center (MSK) will further enhance its ability to offer top cancer care to even more patients with the establishment of a freestanding, state-of-the-art outpatient treatment center in Bergen County, New Jersey. Residents from communities across northern New Jersey and southern New York State will have easier access to MSK’s unique expertise when MSK Bergen becomes fully operational in winter 2017.

… Tuesday, May 10, 2016 Memorial Sloan Kettering Cancer Center (MSK) will further enhance its ability to offer top cancer care to even more patients with the establishment of a freestanding, state-of-the-art outpatient treatment center in Bergen County, New Jersey. Residents from communities across northern

Could an implantable IUD help detect cancer early, when it is most curable? Scientists at the Sloan Kettering Institute are betting yes.

… Tuesday, September 21, 2021 Imagine a device like an Apple Watch that could detect cancer in its earliest stages. The device would communicate with a tiny nanosensor, implanted in your body, that screens for the presence of cancer-associated markers. If any are detected, the sensor sends a signal to

Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation proudly announce that eight distinguished MSK nurses and one nursing team were honored with the 2024 Robbins Family Award for Nursing Excellence. The awards coincide with National Nurses Week (May 6 – 12).

… Friday, May 10, 2024 Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation proudly announce that eight distinguished MSK nurses and one nursing team were honored with the 2024 Robbins Family Award for Nursing Excellence. The awards coincide with National Nurses Week (May 6 –

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Wednesday, January 31, 2024 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Selwyn Vickers Elected to the Fellows of the American Association for Cancer Research Academy Selwyn M. Vickers, MD, FACS , President and CEO, was  elected to the Fellows of the American

Read up on the latest developments in several key areas of cancer research, including genomic mapping, disease modeling through CRISPR, CAR T therapy, and cancer stem cells.

… Monday, April 16, 2018 Summary Memorial Sloan Kettering researchers are featured in more than 150 abstracts and events at this year’s American Association for Cancer Research annual meeting. Their scientific contributions are advancing understanding of all types of cancer. Memorial Sloan Kettering scientists

Scott N. Keeney, a member of the Molecular Biology Program within the Sloan Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute (HHMI) investigator in 2008.

… Wednesday, October 1, 2008 Summary Scott N. Keeney, a member of the Molecular Biology Program within the Sloan Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute (HHMI) investigator in 2008. Scott N. Keeney , a member of the Molecular Biology Program within

Memorial Sloan Kettering Cancer Center (MSKCC) today celebrated a new outpatient chemotherapy center, which is scheduled to open later this month, pending approval from the State Department of Health. The 7,745-square-foot facility, called the Brooklyn Infusion Center, will provide leading-edge chemotherapy services to current MSKCC patients who live in or near Brooklyn - which amounts to more than 15 percent of MSKCC's patients currently being treated in Manhattan.

… Monday, September 13, 2010 Memorial Sloan Kettering Cancer Center (MSKCC) today celebrated a new outpatient chemotherapy center, which is scheduled to open later this month, pending approval from the State Department of Health. The 7,745-square-foot facility, called the Brooklyn Infusion Center , will

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research.

… Monday, November 8, 2021 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce three innovative investigators as the recipients of this year’s  Paul Marks Prize for Cancer Research . The prize, named in honor of MSK’s past President Emeritus, the late Paul Marks, MD, recognizes a new generation

Learn about the aspiring scientists who were celebrated this month for completing a unique summer research program.

… Tuesday, August 28, 2018 Nineteen aspiring scientists were celebrated this month for completing a unique summer research program offered by the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences . Four of the students received special recognition for their outstanding performance and